chemo treatment for stage 1 breast cancer
Tài liệu Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study pdf
Ngày tải lên :
15/02/2014, 04:20
... 2.03 0 .11 11 9.62
ജ50 y old 5 16 0. 31 1.00 3 .19 1. 12 11 .15
Deep vein thrombosis‡ 22 35 0.84 1. 34 1. 60 0. 91 2.86
ഛ49 y old 8 11 0.78 1. 08 1. 39 0. 51 3.99
ജ50 y old 14 24 0.88 1. 51 1. 71 0.85–3.58
*Seven ... 0.55 0.25 1. 15
Spine 31 23 1. 18 0.88 0.74 0. 41 1. 32
Radius, Colles’ 23 14 0.88 0.54 0. 61 0.29 1. 23
Other lower radius* 63 66 2. 41 2.54 1. 05 0.73 1. 51
Total 13 7† 11 1‡ 5.28 4.29 0. 81 0.63 1. 05
ഛ49 ... 23 3 10 .11 1. 43 0 .14 0.03–0.47
5-y predicted breast cancer risk, %
ഛ2.00 35 13 5.54 2.06 0.37 0 .18 –0.72
2. 01 3.00 42 29 5 .18 3. 51 0.68 0. 41 1. 11
3. 01 5.00 43 27 5.88 3.88 0.66 0.39 1. 09
ജ5. 01 55...
- 18
- 645
- 0
báo cáo hóa học: " Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and " potx
Ngày tải lên :
21/06/2014, 01:20
... tumours. Eur
J Cancer 2004, 40(9) :13 73 -13 82.
doi :10 .11 86/ 219 1- 219 X -1- 20
Cite this article as: Rousseau et al.: Syndecan -1 antigen, a promising
new target for triple-negative breast cancer immuno-PET ... MDA-MB-468 xenograft
tumors. EJNMMI Research 2 011 1: 20.
Rousseau et al. EJNMMI Research 2 011 , 1: 20
http://www.ejnmmires.com/content /1/ 1/20
Page 11 of 11
37 MBq
13 1
I-labeled B-B4 mAb. In the 25.9-MBq ... negative early -stage breast cancer. J Clin
Oncol 2006, 24(36):5652-5657.
11 . Oakman C, Viale G, Di Leo A: Management of triple negative breast
cancer. Breast 2 010 , 19 (5): 312 - 21.
12 . Irvin WJ Jr,...
- 11
- 326
- 0
Suggested questions for stage 1
Ngày tải lên :
05/10/2013, 08:48
... interesting building in Guangzhou?
Suggested topics in stage 2 & related questions for
stage 3
Category 1: Describing things (1 test item)
1. Describing a piece of equipment you often use at ... Suggestedquestionsforstage 1
Warm-up
1. Could you show me your identification card please?
2. Could you tell me your full name ... popular?
9. What is the difference between fresh food and canned food?
10 . What can we do to solve the problem of food shortage?
11 . What are the advantages and disadvantages of family food?
2. Describing...
- 10
- 601
- 0
Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-based Chemotherapy and Radiation pptx
Ngày tải lên :
06/03/2014, 01:20
... cancer
Keys, 19 99 (6)
(GOG -12 3)
XRT + CP
XRT
9%
21%
12 %
16 %
Postoperative high-risk cervical cancer
Peters, 19 99 (7)
(SWOG 8797)
XRT + CP/5FU
XRT
6%
17 %
10 %
16 %
* p<0.0 01 ...
10 6 /17 3 ( 61% )
73 /17 7 ( 41% )
0.57
(0.42 to 0.78)
0.55
(0.40 to 0.75)
Whitney, 19 99 (5)
(GOG-85)
10 4
XRT + CP/5FU
XRT + HU
90 /17 7 ( 51% )
76 /19 1 (40%)
0.79
(0.62 to 0.99)
Bulky stage ... cervical cancer
Keys, 19 99 (6)
(GOG -12 3)
36
XRT + CP + hysterectomy
XRT + hysterectomy
14 4 /18 3 (79%)
11 7 /18 6 (63%)
0. 51
(0.34 to 0.75)
Postoperative high-risk cervical cancer
Peters, 19 99...
- 31
- 386
- 0
Guidelines for management of breast cancer ppt
Ngày tải lên :
28/03/2014, 23:20
... research tools.
Stage grouping
Stage 0: Tis, N0, M0
Stage I: T1, N0, M0
Stage IIa: T0, N1, M0
T1, N1, M0
T2, N0, M0
Stage IIb: T2, N1, M0
T3, N0, M0
Stage IIIa: T0, N2, M0
T1, N2, M0
T2, ... patients with breast
cancer ultimately require treatment for advanced disease. Clinical breast cancer research
has focused on effective methods to detect breast cancer at its earliest stages and ... of special problems in breast cancer 37
Figure 13 . Paget’s disease of the nipple-areola complex
Figure 14 . Cancer of the male breast: diagnosis
Diagnosis of breast cancer 15
Prognostic factors
Several...
- 57
- 423
- 0
Báo cáo hóa học: "Morphologic complexity of epithelial architecture for predicting invasive breast cancer survival" ppt
Ngày tải lên :
18/06/2014, 16:20
... 1. 0 67.4 1. 0
1. 56 - 1. 75 14 8 56.4 1. 9 (1. 1, 3.6) 0.03 39.9 2 .1 (1. 2, 3.6) 0.008
> ;1. 75 90 25.0 3.5 (1. 9, 6.4) < 0.0 01 14.2 3.6 (2 .1, 6 .1) < 0.0 01
Age
≤ 55 years 78 82 .1 1.0 82 .1 1.0
>55 ... 2 .1 (1. 1, 3.7) 0. 01 1.7 (1. 1, 3.0) 0.047
Lymph node status
Negative 1. 0 1. 0
Positive 3 .1 (1. 9, 5 .1) < 0.0 01 2.6 (1. 7, 4 .1) < 0.0 01
Estrogen-receptor status
Positive 1. 0 1. 0
Negative 1. 6 ... 0.0 01
Age
≤ 55 years 1. 0 1. 0
>55 years 1. 8 (0.8, 4.2) 0 .14 2.7 (1. 2, 5.9) 0. 01
Size of tumour
≤ 2 cm 1. 0 1. 0
>2 cm 1. 0 (0.6, 1. 6) 0.96 1. 0 (0.7, 1. 6) 0.88
Grade of tumour
1 & 2 1. 0 1. 0
3...
- 10
- 490
- 0
Báo cáo khoa học: " SemiCytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer a prospective pilot study" ppt
Ngày tải lên :
09/08/2014, 08:22
... interleukins-1b, -4, -6, -8, -10 , and tumor
necrosis factors-a, -b: regression analysis of their effect upon oral
squamous cell carcinoma. J Cancer Res Clin Oncol 2008, 13 4:8 21- 832.
doi :10 .11 86 /17 48- 717 X-5 -16
Cite ... 6.7
Docetaxel/5FU/Cisplatin
3
1 6.7
Concomitant Chemotherapy
Carboplatin
4
1 6.7
Cisplatin
5
14 93.3
1
Cisplatin 10 0 mg/m
2
, I.V., day 1; 5-Fluorouracil 10 00 mg/m
2
I.V., continuous
infusion, days 1- 5, every 21 days
2
Carboplatin ... Engl J Med
2004, 350 :19 45 -19 52.
13 . Cooper JS, Bernier J: Rationale for triage in the postoperative
management of head and neck cancers. Oncology 2005, 19 :10 11- 1 017 .
14 . Vissink A, Jansma J, Spijkervet...
- 7
- 341
- 0
Báo cáo y học: "PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers"
Ngày tải lên :
31/10/2012, 16:57
... a potent PARP -1 inhibitor, AG143 61, on BRCA1 mutant and control cancer cells. (A) Clonogenic
survival assay. Five hundred 780 (BRCA1 11 / 11 ), and 525 (BRCA1-/-), and NEU (BRCA1+/+) cells were ... human breast cancer cells using three PARP inhibitors: AG143 61, NU1025, and 3-
aminobenzamide (3AB) [36].
We first tested a BRCA1 mutant ES cell line [BRCA1
trEx 11/
Δ
11
that carries one BRCA1 ... breast cancer, therapeutic treatment, AG143 61
1. Introduction
Breast cancer is the leading cause of cancer
incidence and the second leading cause of cancer
mortality in women. Familial breast cancer...
- 7
- 415
- 0
BREAST CANCER - TREATMENT GUIDELINES FOR PATIENTS potx
Ngày tải lên :
06/03/2014, 01:20
...
When chemotherapy is given after surgery
for early stage breast cancer, it is called
adjuvant chemotherapy. Sometimes chemo-
therapy is given before surgery. This is called
neoadjuvant chemotherapy. ... to have
breast- conserving surgery.
For women whose breast cancer has spread
to other organs in the body (metastases), sys-
temic treatment is the main treatment. This
treatment may be chemotherapy, ... about your cancer or
cancer treatment, please call the American Cancer Society anytime day or night
at 1- 800-ACS-2345.
If a woman and her doctor choose a mas-
tectomy as her breast cancer treatment, ...
- 92
- 411
- 0
Báo cáo hóa học: " A Novel Docetaxel-Loaded Poly (e-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment" pot
Ngày tải lên :
22/06/2014, 00:20
... 0 .17 2 9.76 65.08 -48.70 ± 3 .11 PCL
PFNP 2 01. 7 ± 10 .1 0.096 10 .02 69 .10 -12 .50 ± 0.86 PCL/F68
CCNP 2 81. 2 ± 5.5 0 .14 5 -35.70 ± 2.99 PCL
CFNP 222.7 ± 5.4 0 .13 3 -20.50 ± 1. 34 PCL/F68
Note: Group CCNP ... (2009) 4 :15 30 15 39 15 33
12 3
For example, the MCF-7 TAX30 cell viability after 1 day
incubation at the 10 lg/mL drug concentration was
decreased from 54.37% for Taxotere
Ò
to 49 .16 % (i.e. a
11 .42% ... 23(6), 11 91 11 98 (19 97)
21. G. Storm, S.O. Belliot, T. Daemen, D.D. Lasic, Surface modifi-
cation of nanoparticles to oppose uptake by the mononuclear
phagocyte system. Adv. Drug Deliv. Rev. 16 , 31 48...
- 10
- 363
- 0
báo cáo khoa học: "Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer" pps
Ngày tải lên :
09/08/2014, 01:24
... reported or not applicable 1 (2.3%) 0 (0.0%)
AJCC Class: n (%)
p=NS
Tis 12 (27.3%) 4 (19 .1% )
T1a 1 (2.3%) 3 (14 .3%)
T1b 8 (18 .2%) 4 (19 .1% )
T1c 21 (47.7%) 8 (38 .1% )
T1mic 0 (0.0%) 1 (4.8%)
T2 2 (4.6%) ... Available 4 (9 .1% ) 5 (23.8%)
Not reported 0 (0.0%) 1 (4.8%)
Breast Cup Size
p=NS
B 12 (27.3%) 7 (33.3%)
C 16 (36.4%) 4 (19 .1% )
D 11 (25.0%) 2 (9.5%)
Not reported 5 (11 .4%) 8 (38 .1% )
Lesion Location: ... Differentiated 10 (22.7%) 6 (14 %)
Grade Not Available 4 (9 .1% ) 4 (9%)
Minimum Distance from Balloon to Skin Surface 6 mm 5 mm
Breast Cup Size
A 0 1 (2%)
B 12 (27.3%) 9 ( 21% )
C 16 (36.4%) 15 (35%)
D+ 11 (25.0%)...
- 10
- 389
- 0
Báo cáo khoa học: "Intraoperative radiation therapy in the treatment of early-stage breast cancer utilizing xoft axxent electronic brachytherapy" ppt
Ngày tải lên :
09/08/2014, 04:21
... postopera-
tive whole -breast radiotherapy after breast- conserving
surgery for the management of early -stage invasive breast
cancer (a trial update). Amer J Surg 2007, 19 4:507- 510 .
19 . Vaidya JS, Tobias ... of intra-
operative radiotherapy (IORT) in limited -stage breast can-
cers that are conservatively treated. Eur J Cancer 20 01,
37 (17 ): 217 8- 218 3.
18 . Holmes DR, Baum M, Joseph D: The targit trial: ... Surgical Oncology 2009, 7:24 doi :10 .11 86 /14 77-7 819 -7-24
Received: 17 December 2008
Accepted: 2 March 2009
This article is available from: http://www.wjso.com/content/7 /1/ 24
â 2009 Dickler et al; licensee...
- 6
- 499
- 0
Báo cáo khoa học: "The "Win-Win" initiative: a global, scientifically based approach to resource sparing treatment for systemic breast cancer therapy" pdf
Ngày tải lên :
09/08/2014, 04:21
... palliative breast cancer treatment [10 ]. While
an example of new applications for relatively old and less
expensive drug is the use of Cisplatin in triple negative
breast cancer patients [11 ].
Generic ...
Egypt, for his assistance in preparing the manuscript.
References
1. Sikora K: Developing a global strategy for cancer. Eur J Cancer
19 99, 35 :18 70 -18 77.
2. Stewart BW, Kleihues P: World cancer ... only
five percent of the global resources for cancer control [1] .
Breast cancer is the most frequent cancer among females.
Globally the incidence of breast cancer is increasing, and
the rate of increase...
- 5
- 265
- 0
Báo cáo khoa học: "Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment" doc
Ngày tải lên :
09/08/2014, 07:21
... Black Other p
None, N (%) 10 1 /12 4 ( 81% ) 85/ 91 (93%) . 01
Isolated locoregional 6 /12 4 (5%) 1/ 91 (1% ) .13
Any locoregional 12 /12 4 (10 %) 1/ 91 (1% ) <. 01
Distant 18 /12 4 (15 %) 5/ 91 (5%) .03
Disease-free ... 13 /12 4 (10 %) 17 / 91 (19 %)
Invasive SLNB 51/ 124 ( 41% ) 34/ 91 (38%)
SLNB + ALND 30 /12 4 (24%) 31/ 91 (34%)
ALND 39 /12 4 (32%) 22/ 91 (24%)
None 4 /12 4 (3%) 4/ 91 (4%)
Invasive CT 91/ 124 (73%) 65/ 91 ( 71% )
RT ... CI)
Tumor size .03 1. 1 (1. 0 – 1. 2) <. 01 1.2 (1. 1 – 1. 3)
Node-positive disease .04 1. 5 (1. 0 – 2.3) .02 2.2 (1. 1 – 4.5)
Black race . 01 0.38 (0 .15 – 0.95) .03 0 .12 (0.02 – 1. 0)
Compliance with...
- 10
- 292
- 0
Báo cáo khoa học: " Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: local control and toxicity" potx
Ngày tải lên :
09/08/2014, 09:20
... toxicity
Toxicity No (%)
V
10 0
(cm
3
)
P
‡
V
15 0
(cm
3
)
P
‡
DHI
P
‡
Skin
Yes* 11 (22.9) 51. 3 ± 12 .1 0.2 21 25.7 ± 6.2 0.222 0. 51 ± 0.03 0 .10 5
No 37 (77 .1) 43.0 ± 18 .9 22.0 ± 8.7 0.49 ± 0.03
Subcutaneous ... Harris JR: Breast relapse
following primary radiation therapy for early breast cancer. I.
Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 19 85,
11 :12 71- 1276.
13 . Harris ... with radical mastectomy for early breast
cancer. N Engl J Med 2002, 347 :12 27 -12 32.
6. Morrow M: Rational local therapy for breast cancer. N Engl J Med 2002,
347 :12 70 -12 71.
7. Clarke M, Collins...
- 8
- 339
- 0
